Cargando…

Essential thrombocythemia: Busulphan revisited

Detalles Bibliográficos
Autor principal:	Koduri, Prasad R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854046/ https://www.ncbi.nlm.nih.gov/pubmed/27168714 http://dx.doi.org/10.4103/0971-5851.180147

Ejemplares similares

Outcomes of patients with essential thrombocythemia and unnoticed thrombocytosis prior to diagnosis
por: Lee, Myung-Won, et al.
Publicado: (2020)

A Novel Coincidence: Essential Thrombocythemia with Facioscapulohumeral Muscular Dystrophy
por: Hangül, Ceren, et al.
Publicado: (2020)

A Bone Marrow Biopsy Is Mandatory for a Diagnosis of Essential Thrombocythemia
por: Kobayashi, Zen
Publicado: (2019)

Distinct molecular abnormalities underlie unique clinical features of essential thrombocythemia in children
por: Fu, R, et al.
Publicado: (2016)

Busulphan in the Treatment of Chronic Granulocytic Leukaemia
por: Bridges, J. M., et al.
Publicado: (1961)

MPL mutations and palpable splenomegaly are independent risk factors for fibrotic progression in essential thrombocythemia
por: Haider, M, et al.
Publicado: (2016)

The Authors' Reply to “A Bone Marrow Biopsy Is Mandatory for a Diagnosis of Essential Thrombocythemia”
por: Kato, Yuji, et al.
Publicado: (2019)

Chronic urticaria reveals JAK2V617F positive essential thrombocythemia
por: Albanesi, Marcello, et al.
Publicado: (2021)

Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia
por: Barbui, T, et al.
Publicado: (2015)

Differences in Hematological and Clinical Features Between Essential Thrombocythemia Cases With JAK2- or CALR-Mutations
por: Kubuki, Yoko, et al.
Publicado: (2017)

Application of current prognostic models for primary myelofibrosis in the setting of post-polycythemia vera or post-essential thrombocythemia myelofibrosis
por: Tefferi, A, et al.
Publicado: (2017)

Essential thrombocythemia
por: Brière, Jean B
Publicado: (2007)

Lower response to BNT162b2 vaccine in patients with myelofibrosis compared to polycythemia vera and essential thrombocythemia
por: Pimpinelli, Fulvia, et al.
Publicado: (2021)

Concomitant Diagnosis of Primary Bone Marrow B-Cell Non-Hodgkin Lymphoma and Essential Thrombocythemia: A Case Report
por: Kim, Hongkyung, et al.
Publicado: (2022)

Ruxolitinib for essential thrombocythemia?
por: Bose, Prithviraj, et al.
Publicado: (2017)

Simultaneous presentation of JAK2 V617F mutation-related essential thrombocythemia and B-cell chronic lymphocytic leukemia
por: D'Angelo, Guido, et al.
Publicado: (2014)

The Effect of Cysteine on the Immunosuppressive Activity of Busulphan, Cyclophosphamide and Nitrogen Mustard
por: Addison, I. E., et al.
Publicado: (1971)

Frequent CALR exon 9 alterations in JAK2 V617F-mutated essential thrombocythemia detected by high-resolution melting analysis
por: Lim, K-H, et al.
Publicado: (2015)

Concomitant transformation of monoclonal gammopathy of undetermined significance to multiple myeloma and of essential thrombocythemia to acute biphenotypic leukemia 37 years after initial diagnosis
por: Niscola, Pasquale, et al.
Publicado: (2013)

Reduced lethality in mice receiving a combined dose of cyclophosphamide and busulphan.
por: Millar, J. L., et al.
Publicado: (1975)

Emerging treatments for essential thrombocythemia
por: Okoli, Steven, et al.
Publicado: (2011)

Thromboembolic complication in Essential Thrombocythemia
por: Mozaheb, Zahra
Publicado: (2012)

Ruxolitinib for the Treatment of Essential Thrombocythemia
por: Gunawan, Arief, et al.
Publicado: (2018)

Essential Thrombocythemia in Children and Adolescents
por: Putti, Maria Caterina, et al.
Publicado: (2021)

Mutations and thrombosis in essential thrombocythemia
por: Guglielmelli, Paola, et al.
Publicado: (2021)

The Use of Anagrelide in Myeloproliferative Neoplasms, with Focus on Essential Thrombocythemia
por: Birgegård, Gunnar
Publicado: (2016)

Autoinflammation and Myelofibrosis: Report of a Case
por: Koduri, Prasad R., et al.
Publicado: (2023)

Biodistribution of biodegradable polymeric nano-carriers loaded with busulphan and designed for multimodal imaging
por: Asem, Heba, et al.
Publicado: (2016)

Flavin-containing monooxygenase 3 (FMO3) role in busulphan metabolic pathway
por: El-Serafi, Ibrahim, et al.
Publicado: (2017)

Moyamoya syndrome in an adult with essential thrombocythemia
por: Lazzaro, Marc A., et al.
Publicado: (2011)

Essential thrombocythemia: Rare cause of chorea
por: Venkatesan, Eswaradass Prasanna, et al.
Publicado: (2014)

Mutant calreticulin causes essential thrombocythemia
por: Shimoda, Kazuya, et al.
Publicado: (2017)

Essential thrombocythemia treatment algorithm 2018
por: Tefferi, Ayalew, et al.
Publicado: (2018)

Essential Thrombocythemia Presenting as Paraneoplastic Glomerulonephritis
por: Abdulla, M. C., et al.
Publicado: (2018)

Concomitant constitutive LNK and NFE2 mutation with loss of sumoylation in a case of hereditary thrombocythemia
por: Böckelmann, Lukas Clemens, et al.
Publicado: (2021)

Site‐specific venous thrombosis in essential thrombocythemia: Impact on subsequent vascular events and survival
por: Gangat, Naseema, et al.
Publicado: (2022)

A Young Adult With Essential Thrombocythemia Presenting as Myocardial Infarction
por: Ganta, Nagapratap, et al.
Publicado: (2022)

Chorea Associated with JAK2(V617F) ‐Positive Essential Thrombocythemia
por: Calculli, Alessandra, et al.
Publicado: (2022)

Correction: Flavin-containing monooxygenase 3 (FMO3) role in busulphan metabolic pathway
Publicado: (2017)

Marrow iron staining should always be performed to diagnose Myelodysplastic/myeloproliferative neoplasia with ring sideroblasts and thrombocythemia.
por: Chauffaille, Maria de Lourdes Lopes Ferrari, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4enfv7ghu5nobiptsh3k0sih5e